Epilepsy, Nocturnal Frontal Lobe, Type 3
|
0.900 |
Biomarker
|
disease |
MGD |
Altered activity-rest patterns in mice with a human autosomal-dominant nocturnal frontal lobe epilepsy mutation in the β2 nicotinic receptor.
|
20603624 |
2011 |
Epilepsy, Nocturnal Frontal Lobe, Type 3
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy.
|
11104662 |
2001 |
Epilepsy, Nocturnal Frontal Lobe, Type 3
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy.
|
11104662 |
2001 |
Epilepsy, Nocturnal Frontal Lobe, Type 3
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chromosome 1.
|
11094099 |
2000 |
Epilepsy, Nocturnal Frontal Lobe, Type 3
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy.
|
11062464 |
2000 |
Epilepsy, Nocturnal Frontal Lobe, Type 3
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy.
|
11062464 |
2000 |
Epilepsy, Nocturnal Frontal Lobe, Type 3
|
0.900 |
Biomarker
|
disease |
CTD_human |
|
|
|
Epilepsy, Nocturnal Frontal Lobe, Type 3
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Epilepsy, Nocturnal Frontal Lobe, Type 3
|
0.900 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
To investigate this issue of phenotypic heterogeneity, we prospectively carried out a high-resolution 3-T magnetic resonance imaging (MRI) study in an ADNFLE family containing 10 affected members including one pharmacoresistant patient and carrying the V287L mutation of the CHRN beta2 subunit (CHRNB2).
|
22897520 |
2013 |
Attention Deficit Disorder
|
0.500 |
Biomarker
|
disease |
CTD_human |
Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study.
|
21748252 |
2012 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A case of autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) coexisting with pervasive developmental disorder harboring SCN1A mutation in addition to CHRNB2 mutation.
|
23032131 |
2012 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is a rare familial seizure disorder caused by mutations in at least two different subunit genes of the neuronal nicotinic acetylcholine receptor (nAChR), CHRNA4 and CHRNB2.
|
22036597 |
2012 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is partly caused by mutations in the nicotinic acetylcholine receptor (nAChR) genes CHRNA4, CHRNB2, and CHRNA2.
|
21497487 |
2011 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) can be caused by mutations in the neuronal nicotinic acetylcholine receptor (nAChR) subunit genes CHRNA4 and CHRNB2.
|
19383498 |
2009 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In order to assess the genetic defects in NFLE, we performed a mutation screening in 33 unrelated patients with sporadic NFLE by amplifying and sequencing bidirectionally TM 1-3 of CHRNA4, CHRNB2 and CHRNA2 which contain the mutations reported in ADNFLE.
|
19058950 |
2009 |
Attention Deficit Disorder
|
0.500 |
Biomarker
|
disease |
MGD |
Retinal waves in mice lacking the beta2 subunit of the nicotinic acetylcholine receptor.
|
18757739 |
2008 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Autosomal dominant nocturnal frontal lobe epilepsy and mild memory impairment associated with CHRNB2 mutation I312M in the neuronal nicotinic acetylcholine receptor.
|
18534914 |
2008 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutation analysis of the CHRNB2 gene revealed a c.859G>A transition (Val287Met) within the second transmembrane domain, identical to that previously described in a Scottish ADNFLE family.
|
17900292 |
2008 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
Biomarker
|
disease |
BEFREE |
Certain mutations in specific parts of the neuronal nicotinic acetylcholine receptor (nAChR) subunit genes CHRNA4, CHRNB2, and probably CHRNA2, can cause autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).
|
18456869 |
2008 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is known to be caused by mutations in the transmembrane regions of the neuronal nicotinic acetylcholine receptor (nAChR) genes CHRNA4 and CHRNB2.
|
17602836 |
2007 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
Biomarker
|
disease |
BEFREE |
Although over hundred families are on record, only a minority of them have been linked to mutations in the genes coding for the alpha4, alpha2 and beta2 (CHRNA4, CHRNA2, and CHRNB2) subunits of the nAChRs, indicating that ADNFLE is genetically heterogeneous despite a relatively homogeneous clinical picture.
|
17662253 |
2007 |
Attention Deficit Disorder
|
0.500 |
Biomarker
|
disease |
MGD |
Control of breathing in newborn mice lacking the beta-2 nAChR subunit.
|
15450117 |
2004 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations responsible for autosomal dominant nocturnal frontal lobe epilepsy have been identified in two members of the neuronal nicotinic acetylcholine receptor gene family: CHRNA4(ENFL1 locus) and CHRNB2 (ENFL3 locus) coding for alpha4 and beta2 subunit, respectively.
|
15245761 |
2004 |
Attention Deficit Disorder
|
0.500 |
Biomarker
|
disease |
MGD |
Executive and social behaviors under nicotinic receptor regulation.
|
12876201 |
2003 |